{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:30:36Z","timestamp":1786120236754,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/adm.0b013e3182266a3a","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T15:46:39Z","timestamp":1317743199000},"page":"293-299","source":"Crossref","is-referenced-by-count":64,"title":["The Relationship Between Maternal Opioid Agonists and Psychiatric Medications on Length of Hospitalization for Neonatal Abstinence Syndrome"],"prefix":"10.1097","volume":"5","author":[{"given":"Elisha M.","family":"Wachman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.K.","family":"Newby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Vreeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Bonganzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Bauchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara L.","family":"Philipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"2","key":"R1-9-20210126","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1067\/S0002-9378(03)00520-9","article-title":"Maternal methadone dose and neonatal withdrawal.","volume":"189","author":"Berghella","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"R2-9-20210126","first-page":"80","article-title":"Prospective randomized comparative study of the effect of buprenorphine, methadone, and heroin on the course of pregnancy, birth weight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.","volume":"29","author":"Binder","year":"2008","journal-title":"Neuro Endocrinol Lett"},{"issue":"3","key":"R4-9-20210126","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.drugalcdep.2004.03.012","article-title":"Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure.","volume":"75","author":"Choo","year":"2004","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"R5-9-20210126","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11096-007-9176-1","article-title":"Hospital morphine preparation for abstinence syndrome in newborns exposed to buprenorphine or methadone.","volume":"30","author":"Colombini","year":"2008","journal-title":"Pharm World Sci"},{"issue":"5","key":"R6-9-20210126","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1471-0528.2008.02073.x","article-title":"Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.","volume":"116","author":"Dryden","year":"2009","journal-title":"BJOG"},{"issue":"4","key":"R7-9-20210126","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1515\/JPM.2007.063","article-title":"Sequela of preterm versus term infants born to mothers on a methadone maintenance program: differential course of neonatal abstinence syndrome.","volume":"35","author":"Dysart","year":"2007","journal-title":"J Perinat Med"},{"issue":"2-3","key":"R8-9-20210126","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.drugalcdep.2006.08.024","article-title":"Management of neonatal abstinence syndrome in neonates born to opioid maintained women.","volume":"87","author":"Ebner","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"R9-9-20210126","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/070674370304800207","article-title":"A multicentre prospective controlled study to determine the safety of trazadone and nefazodone use during pregnancy.","volume":"48","author":"Einarson","year":"2003","journal-title":"Can J Psychiatry"},{"issue":"12","key":"R10-9-20210126","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/pds.1084","article-title":"Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies.","volume":"14","author":"Einarson","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R12-9-20210126","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1360-0443.2006.01321.x","article-title":"Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study.","volume":"101","author":"Fischer","year":"2006","journal-title":"Addiction"},{"issue":"1","key":"R13-9-20210126","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jsat.2006.06.015","article-title":"Mood disorders affect drug treatment success of drug-dependent pregnant women.","volume":"32","author":"Fitzsimons","year":"2007","journal-title":"J Subst Abuse Treat"},{"issue":"7-8","key":"R15-9-20210126","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1345\/aph.1D485","article-title":"Clinical utilization of atypical antipsychotics in pregnancy and lactation.","volume":"38","author":"Gentile","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"10","key":"R16-9-20210126","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1176\/appi.ajp.159.10.1667","article-title":"Management of major depression during pregnancy.","volume":"159","author":"Hendrick","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"1","key":"R17-9-20210126","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1176\/appi.ps.53.1.39","article-title":"Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant.","volume":"53","author":"Iqbal","year":"2002","journal-title":"Psychiatr Serv"},{"issue":"1","key":"R18-9-20210126","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5055\/jom.2009.0006","article-title":"The opioid-exposed newborn: assessment and pharmacologic management.","volume":"5","author":"Jansson","year":"2009","journal-title":"J Opioid Manag"},{"issue":"1","key":"R19-9-20210126","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0376-8716(00)00194-0","article-title":"Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes.","volume":"63","author":"Johnson","year":"2001","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"R20-9-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.11.013","article-title":"Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.","volume":"79","author":"Jones","year":"2005","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"R21-9-20210126","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/clpt.2008.156","article-title":"Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes.","volume":"84","author":"Kacinko","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"1-2","key":"R22-9-20210126","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.drugalcdep.2008.01.025","article-title":"Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.","volume":"96","author":"Kakko","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"R23-9-20210126","first-page":"107","article-title":"Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome.","volume":"45","author":"Klinger","year":"2008","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"R24-9-20210126","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1056\/NEJMra020617","article-title":"Management of drug and alcohol withdrawal.","volume":"348","author":"Kosten","year":"2003","journal-title":"N Engl J Med"},{"issue":"3","key":"R25-9-20210126","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.drugalcdep.2005.10.001","article-title":"Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution.","volume":"82","author":"Lejeune","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"R26-9-20210126","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archpedi.160.2.173","article-title":"Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.","volume":"160","author":"Levinson-Castiel","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"R28-9-20210126","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/10550490902772975","article-title":"Psychopharmacologic management of opioid-dependent women during pregnancy.","volume":"18","author":"Martin","year":"2009","journal-title":"Am J Addict"},{"issue":"2","key":"R31-9-20210126","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2190\/JDTX-BYC3-K3VP-LWAH","article-title":"Tricyclic drugs in pregnancy and lactation: a preliminary report.","volume":"21","author":"Misri","year":"1991","journal-title":"Int J Psychiatry Med"},{"issue":"19","key":"R32-9-20210126","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1001\/jama.293.19.2372","article-title":"Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.","volume":"293","author":"Moses-Kolko","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"R33-9-20210126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1124\/jpet.300.1.26","article-title":"Transplacental transfer and metabolism of buprenorphine.","volume":"300","author":"Nanovskaya","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"R35-9-20210126","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1176\/appi.ajp.2007.06111886","article-title":"Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes.","volume":"164","author":"Newport","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"1-2","key":"R36-9-20210126","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1440-1754.2007.00994.x","article-title":"Management of the newborn infant affected by maternal opiates and other drugs of dependency.","volume":"43","author":"Oei","year":"2007","journal-title":"J Paediatr Child Health"},{"issue":"9458","key":"R37-9-20210126","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(05)17865-9","article-title":"Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis.","volume":"365","author":"Sanz","year":"2005","journal-title":"Lancet"},{"key":"R38-9-20210126","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.jp.7211427","article-title":"Management of neonatal abstinence syndrome in the neonatal intensive care units: a national survey.","volume":"26","author":"Sarkar","year":"2006","journal-title":"J Perinatol"},{"issue":"1","key":"R39-9-20210126","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1360-0443.2003.00245.x","article-title":"Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy.","volume":"98","author":"Schindler","year":"2003","journal-title":"Addiction"},{"issue":"4","key":"R43-9-20210126","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1592\/phco.27.4.546","article-title":"Safety of newer antidepressants in pregnancy.","volume":"27","author":"Way","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"12","key":"R44-9-20210126","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1176\/appi.ajp.157.12.1933","article-title":"Risk-benefit decision making for treatment of depression during pregnancy.","volume":"157","author":"Wisner","year":"2000","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Addiction Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01271255-201112000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:18:19Z","timestamp":1786047499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01271255-201112000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/adm.0b013e3182266a3a","relation":{},"ISSN":["1932-0620"],"issn-type":[{"value":"1932-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}